Minimal Residual Disease Monitoring from Liquid Biopsy By Next Generation Sequencing in Follicular Lymphoma Patients

被引：2
|
作者：
Ubieto, Ana Isabel Jiminez
Heredia, Yanira
de la Rosa, Juan Manuel
Izquierdo, Antonia Rodriguez
Rufian, Laura
Carrillo, Jaime
Sanchez, Ricardo
Onecha, Esther
Wang, Chongwu
Sarandeses, Pilar
Poza, Maria
Barcena, Carmen
Grande, Carlos
Canales, Miguel A.
Rapado, Inmaculada
Ayala, Rosa
Gallardo, Miguel
Martinez-Lopez, Joaquin
Barrio, Santiago
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-139256
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Developing the liquid biopsy in gastroesophageal adenocarcinoma: Disease monitoring and detection of minimal residual disease
    Openshaw, M. R.
    Ottolini, B.
    Richards, C. J.
    Guttery, D.
    Shaw, J. A.
    Thomas, A.
    ANNALS OF ONCOLOGY, 2018, 29 : 662 - 662
  • [32] A comparative analysis of next-generation sequencing and t(14;18) real-time quantitative PCR for Minimal Residual Disease Detection (MRD) in Follicular lymphoma
    Pott, C.
    Monitillo, L.
    Genuardi, E.
    Mantoan, B.
    Trautmann, H.
    Kneba, M.
    Fuellgrabe, M.
    Brueggemann, M.
    Faham, M.
    Ladetto, M.
    ONKOLOGIE, 2013, 36 : 31 - 31
  • [33] Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
    Yao, Qiumei
    Bai, Yinlei
    Orfao, Alberto
    Chim, Chor Sang
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [34] IGH AND IGK CLONAL TRACKING FOR MINIMAL RESIDUAL DISEASE MONITORING IN MULTIPLE MYELOMA BY NEXT GENERATION SEQUENCING: A BOLOGNA EXPERIENCE
    Armuzzi, S.
    Martello, M.
    Borsi, E.
    Solli, V.
    Poletti, A.
    Agboyi, L.
    Vigliotta, I.
    Zamagni, E.
    Pantani, L.
    Rocchi, S.
    Mancuso, K.
    Tacchetti, P.
    Rizzello, I.
    Cavo, M.
    Terragna, C.
    HAEMATOLOGICA, 2020, 105 : S42 - S43
  • [35] Digital droplet PCR and next-generation sequencing refine minimal residual disease monitoring in acute lymphoblastic leukemia
    Della Starza, Irene
    De Novi, Lucia Anna
    Santoro, Alessandra
    Salemi, Domenico
    Tam, Wayne
    Cavalli, Marzia
    Menale, Lucia
    Soscia, Roberta
    Apicella, Valerio
    Ilari, Caterina
    Vitale, Antonella
    Testi, Anna Maria
    Inghirami, Giorgio
    Chiaretti, Sabina
    Foa, Robin
    Guarini, Anna
    LEUKEMIA & LYMPHOMA, 2019, 60 (11) : 2838 - 2840
  • [36] Next-Generation Sequencing Based Minimal Residual Disease Assessment in Peripheral Blood RNA from Multiple Myeloma Patients
    Wolf, Jeffrey L.
    Kong, Katherine A.
    Wilmoth, Jenai
    Bayes, Joshua
    Marsala, Amy
    Carlton, Victoria
    Logan, Aaron
    Martin, Thomas G., III
    BLOOD, 2016, 128 (22)
  • [37] Accurate and efficient Next-Generation Sequencing approach for liquid biopsy detection and monitoring
    Chen, Cai
    Kasbek, Christopher
    Song, Yang
    Chen, Si
    Almalki, Nouran
    Li, Jiangyu
    Wan, Yifei
    Huang, Jun
    Ding, Wei
    CANCER RESEARCH, 2019, 79 (13)
  • [38] Minimal residual disease as a target for liquid biopsy in patients with solid tumours
    Pantel, Klaus
    Alix-Panabieres, Catherine
    NATURE REVIEWS CLINICAL ONCOLOGY, 2025, 22 (01) : 65 - 77
  • [39] HASHCLONE: A NEW BIOINFORMATICS SUITE TO QUANTIFY MINIMAL RESIDUAL DISEASE BY NEXT-GENERATION SEQUENCING IN B-CELL LYMPHOMA
    Genuardi, E.
    Beccuti, M.
    Romano, G.
    Monitillo, L.
    Barbero, D.
    Furia, F.
    Calogero, R.
    Boccadoro, M.
    Ladetto, M.
    Cordero, F.
    Ferrero, S.
    HAEMATOLOGICA, 2017, 102 : 52 - 53
  • [40] Quantitative molecular monitoring of circulating lymphoma cells for the detection of minimal residual disease in follicular and mantle cell lymphoma
    Schüler, F
    Hirt, C
    Dölken, L
    Krüger, W
    Dölken, G
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2005, 130 (38) : 2130 - 2134
12345